InvestorsHub Logo
Followers 6
Posts 644
Boards Moderated 0
Alias Born 10/09/2013

Re: None

Wednesday, 12/16/2015 8:55:31 AM

Wednesday, December 16, 2015 8:55:31 AM

Post# of 10348
I would love to know who is sitting on the offer at .22 thinking that is the right price to sell his/her shares after the company announces that they are starting human clinical trials.

The stock went to 1.25 on speculation of greatness, 2 years ago.

The stock went to .50 on speculation of progress.

We are not at .21 with human clinical trial approval (with a 6 month window for a CE Mark and full product in the marketplace) and people are selling it at .22

Somebody please explain the rationale there?